Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Iron in Children With Chronic Kidney Disease
Sponsor: Weill Medical College of Cornell University
Summary
This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and changes in eating behavior, which will be measured at enrollment and at the end of the study period.
Official title: Pilot Pragmatic Clinical Trial of Oral Iron Therapy in Children With Chronic Kidney Disease
Key Details
Gender
All
Age Range
1 Year - 21 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2019-04-19
Completion Date
2028-12-31
Last Updated
2025-08-11
Healthy Volunteers
No
Interventions
Ferrous Sulfate
Oral iron will be given in the form of immediate-release iron sulfate, 3-6 mg/kg/day of elemental iron to children with body weight ≤43 kg, and 65 mg of elemental iron (325 mg of iron sulfate) to children with body weight \>43 kg.
Locations (2)
Weill Cornell Medicine / New York Presbyterian Hospital
New York, New York, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States